General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Details Narrative) (OWP Ventures, Inc.)

v3.19.3
Stockholders' Equity (Details Narrative) (OWP Ventures, Inc.) - USD ($)
2 Months Ended 3 Months Ended 9 Months Ended
Feb. 18, 2019
Dec. 14, 2018
Nov. 30, 2018
Nov. 22, 2018
Nov. 09, 2018
Oct. 30, 2018
Oct. 24, 2018
Oct. 04, 2018
Sep. 20, 2018
Jul. 28, 2018
Jun. 15, 2018
May 30, 2018
Mar. 26, 2018
Feb. 19, 2019
Jun. 20, 2018
Feb. 05, 2019
Dec. 31, 2018
Jun. 30, 2019
Jan. 10, 2019
Common stock, shares authorized                                 75,000,000 75,000,000 75,000,000
Common stock, par value                                 $ 0.001 $ 0.001  
Common stock, shares issued                                 34,291,905 39,922,899  
Common stock, shares outstanding                                 34,291,905 39,922,899  
Number of stock issued for services, value                                 $ 285,600    
Equity method investment, ownership percentage                                   4.99%  
Non-trading shares of common stock issued                                 162,909    
Contributed capital                                 $ 136,440    
OWP Ventures, Inc. [Member]                                      
Common stock, shares authorized                                 200,000,000    
Common stock, par value                               $ 0.001 $ 0.0001 $ 0.0001  
Common stock, shares issued                                 34,291,905    
Common stock, shares outstanding                                 34,291,905    
Number of stock sold   100,000           357,143 238,095 476,191 1,190,476     3,900,000          
Sale of stock price per share   $ 0.50           $ 0.42 $ 0.42 $ 0.42 $ 0.42     $ 0.50          
Number of stock sold, value   $ 50,000           $ 150,000 $ 100,000 $ 200,000 $ 500,000     $ 1,950,000          
Number of stock issued for services 30,000         630,000 50,000                        
Number of stock issued for services, value $ 15,000         $ 264,600 $ 21,000                        
Share issued price per share $ 0.50         $ 0.42 $ 0.42                        
Equity method investment, ownership percentage     66.20% 66.20%                         4.99%    
Business combination, purchase consideration     $ 350,000 $ 350,000                              
Goodwill     $ 349,420 $ 349,420 [1]                              
OWP Ventures, Inc. [Member] | One World Pharma S.A.S. [Member]                                      
Number of stock issued                       10,200,000              
Equity method investment, ownership percentage                       100.00%              
Non-trading shares of common stock issued, shares                       10,200,000              
Non-trading shares of common stock issued                       $ 162,909              
OWP Ventures, Inc. [Member] | Subscriptions Receivable [Member]                                      
Number of stock sold, value         $ 485                            
OWP Ventures, Inc. [Member] | Chief Executive Officer [Member]                                      
Number of stock sold                         100            
Sale of stock price per share                         $ 0.10            
Number of stock sold, value                         $ 10            
OWP Ventures, Inc. [Member] | Chief Executive Officer [Member] | Subscriptions Receivable [Member]                                      
Number of stock sold                         4,844,900            
Sale of stock price per share                         $ 0.0001            
OWP Ventures, Inc. [Member] | Nine Founders [Member]                                      
Number of stock sold                         16,205,000            
Sale of stock price per share                         $ 0.0001            
Number of stock sold, value                               $ 1,620      
OWP Ventures, Inc. [Member] | CEO [Member]                                      
Contributed capital                             $ 136,440        
[1] The consideration paid in excess of the net fair value of assets acquired and liabilities assumed has been recognized as additional paid-in capital due to the subsequent reverse merger.